BWL
RXRX icon

Bogart Wealth LLC’s Recursion Pharmaceuticals RXRX Stock Holding History

Bogart Wealth LLC’s Portfolio RXRX Stock Details RXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$117 Hold
38
– – ﹤0.01% 1733
2025
Q4 		$155 Sell
38
-4,000
-99% -$19.8K ﹤0.01% 1543
2025
Q3 		$19.7K Buy
4,038
+4,000
+10,526% +$21K ﹤0.01% 668
2025
Q2 		$192 Hold
38
– – ﹤0.01% 1407
2025
Q1 		$201 Buy
+38
New +$277 ﹤0.01% 1355

Other funds holding RXRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SoftBank Group
SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MCMU
MIC Capital Management (UK) London, United Kingdom $352M AUM 0.23% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bogart Wealth LLC's RXRX Position: Q1 2026 in Review

Bogart Wealth LLC held its Recursion Pharmaceuticals (RXRX) position steady in Q1 2026 at 38 shares worth $117. The position accounts for ﹤0.01% of the portfolio, ranked #1733.

Bogart Wealth LLC first reported a position in RXRX in Q1 2025 and has held it in 5 quarters since. The position peaked at $19.7K in Q3 2025. 334 funds tracked by Wall St. Rank hold RXRX as of Q1 2026.

  • Bogart Wealth LLC held 38 shares of Recursion Pharmaceuticals worth $117 as of Q1 2026.
  • Bogart Wealth LLC left its Recursion Pharmaceuticals share count unchanged in Q1 2026.
  • Recursion Pharmaceuticals made up ﹤0.01% of Bogart Wealth LLC's portfolio in Q1 2026, its #1733 holding.
  • Bogart Wealth LLC first reported a position in Recursion Pharmaceuticals in Q1 2025 and has held it in 5 quarters since.
  • Bogart Wealth LLC's Recursion Pharmaceuticals position peaked at $19.7K in Q3 2025.
  • 334 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q1 2026.

Based on Bogart Wealth LLC's 13F filing for Q1 2026, filed 28 Apr 2026.